Detalhe da pesquisa
1.
Crotonylation at serine 46 impairs p53 activity.
Biochem Biophys Res Commun
; 524(3): 730-735, 2020 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32035620
2.
Strategies to target the Hedgehog signaling pathway for cancer therapy.
Med Res Rev
; 38(3): 870-913, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29315702
3.
Phytometabolites as modulators of breast cancer: a comprehensive review of mechanistic insights.
Med Oncol
; 41(2): 45, 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38172452
4.
Virtual screening and molecular dynamics simulation approach for the identification of potential multi-target directed ligands for the treatment of Alzheimer's disease.
J Biomol Struct Dyn
; 42(1): 509-527, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37114423
5.
A comprehensive review on pharmacognosy, phytochemistry and pharmacological activities of 8 potent species of southeast Asia.
J Tradit Chin Med
; 44(3): 620-628, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38767647
6.
Exploring the Potential of Essential Oil from Plectranthus amboinicus Leaves against Breast Cancer: In vitro and In silico Analysis.
Med Oncol
; 41(4): 81, 2024 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400892
7.
An amalgamated molecular dynamic and Gaussian based 3D-QSAR study for the design of 2,4-thiazolidinediones as potential PTP1B inhibitors.
J Mol Graph Model
; 127: 108695, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38118354
8.
Nutrient-epigenome interactions: Implications for personalized nutrition against aging-associated diseases.
J Nutr Biochem
; 127: 109592, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38325612
9.
Elacestrant: a new FDA-approved SERD for the treatment of breast cancer.
Med Oncol
; 40(6): 180, 2023 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37191763
10.
Selective Estrogen receptor degraders (SERDs) for the treatment of breast cancer: An overview.
Eur J Med Chem
; 256: 115422, 2023 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37163948
11.
Current Insights into the Role of BRAF Inhibitors in Treatment of Melanoma.
Anticancer Agents Med Chem
; 23(3): 278-297, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-35761499
12.
Dual aromatase-steroid sulfatase inhibitors (DASI's) for the treatment of breast cancer: a structure guided ligand based designing approach.
J Biomol Struct Dyn
; 41(20): 10604-10626, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36510679
13.
Molecular docking, 3D-QSAR and simulation studies for identifying pharmacophoric features of indole derivatives as 17ß-hydroxysteroid dehydrogenase type 5 (17ß-HSD5) inhibitors.
J Biomol Struct Dyn
; 41(22): 12668-12685, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36744535
14.
Microsponges as Drug Delivery System: Past, Present, and Future Perspectives.
Curr Pharm Des
; 29(13): 1026-1045, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37013425
15.
Molecular dynamics and 3D-QSAR studies on indazole derivatives as HIF-1α inhibitors.
J Biomol Struct Dyn
; 41(8): 3524-3541, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35318905
16.
Recent Advancements in the Discovery of MDM2/MDM2-p53 Interaction Inhibitors for the Treatment of Cancer.
Curr Med Chem
; 30(32): 3668-3701, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37190755
17.
Current development of 1,2,3-triazole derived potential antimalarial scaffolds: Structure- activity relationship (SAR) and bioactive compounds.
Eur J Med Chem
; 259: 115699, 2023 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37542987
18.
Developing our knowledge of the quinolone scaffold and its value to anticancer drug design.
Expert Opin Drug Discov
; 18(10): 1151-1167, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37592843
19.
Pharmacophore derived 3D-QSAR, molecular docking, and simulation studies of quinoxaline derivatives as ALR2 inhibitors.
J Biomol Struct Dyn
; : 1-37, 2023 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37698364
20.
Boron in cancer therapeutics: An overview.
Pharmacol Ther
; 251: 108548, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37858628